Rabbit Anti-KRT2 Recombinant Antibody (VS3-CJ912) (CAT#: VS3-CJ912)
This product is a rabbit antibody that recognizes human KRT2.
Specific Inquiry
Custom Production
We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.
We require custom production
Subcellular Location
Normal Tissue
RNA Expression
Figure 1 IF staining of human cell line U-2 OS
(Immunofluorescent staining of human cell line U-2 OS shows localization to cytosol & intermediate filaments.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/6299/if_selected.jpg
(Immunofluorescent staining of human cell line U-2 OS shows localization to cytosol & intermediate filaments.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/6299/if_selected.jpg
Figure 2 High expression in skin 1.
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/37321/140905_B_7_1_selected.jpg
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/37321/140905_B_7_1_selected.jpg
Figure 3 Low expression in colon.
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/37321/140905_A_7_3_val_selected.jpg
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/37321/140905_A_7_3_val_selected.jpg
Figure 4 Skin
(Cells in basal layer Staining: Low Intensity: Weak Quantity:>75% Cells in corneal layer Staining: Medium Intensity: Moderate Quantity:>75% Cells in granular layer Staining: High Intensity: Strong Quantity:>75% Cells in spinous layer Staining: High Intensity: Strong Quantity: 75%-25%)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/37321/140905_B_7_1.jpg
(Cells in basal layer Staining: Low Intensity: Weak Quantity:>75% Cells in corneal layer Staining: Medium Intensity: Moderate Quantity:>75% Cells in granular layer Staining: High Intensity: Strong Quantity:>75% Cells in spinous layer Staining: High Intensity: Strong Quantity: 75%-25%)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/37321/140905_B_7_1.jpg
Figure 5 RNA cell line category: Cell line enhanced (HEL)
(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/ENSG00000172867-KRT2
(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/ENSG00000172867-KRT2
Specifications
- Immunogen
- Recombinant protein
- Host Species
- Rabbit
- Type
- Rabbit IgG
- Specificity
- Human KRT2
- Species Reactivity
- Human
- Applications
- WB, IHC
- Conjugate
- Unconjugated
Product Property
- Purification
- Protein A affinity purified
- Purity
- >95% as determined by SDS-PAGE
- Format
- Liquid
- Buffer
- 40% Glycerol, 1% BSA, TBS, pH7.4.
- Preservative
- 0.05% Sodium Azide
- Storage
- Store at 4°C for short term. Aliquot and store at -20°C for long term. Avoid repeated freeze/thaw cycles.
Applications
- Application Notes
- This antibody has been tested for use in Western Blot, Immunohistochemistry.
Target
- Alternative Names
- K2e; KRTE; CK-2e; KRT2A; KRT2E
- Gene ID
- 3849
- UniProt ID
- P35908
- Sequence Similarities
- Belongs to the intermediate filament family.
- Cellular Localization
- Cytoplasm, Intermediate filament, Keratin
- Protein Refseq
- NP_000414.2
- Function
- Probably contributes to terminal cornification (PubMed:1380918).
Associated with keratinocyte activation, proliferation and keratinization (PubMed:12598329).
Required for maintenance of corneocytes and keratin filaments in suprabasal keratinocytes in the epidermis of the ear, potentially via moderation of expression and localization of keratins and their partner proteins (By similarity).
Plays a role in the establishment of the epidermal barrier on plantar skin (By similarity).
Recommended Products
Isotype Control
Secondary Antibody
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "KRT2"
Select a product category from the dropdown menu below to view related products.
Please select product type
IgG Antibody Products
Rabbit Monoclonal Antibody Products
IHC Kit and Antibody Products: Precision Tools for Immunohistochemistry
| CAT | Product Name | Application | Type |
|---|---|---|---|
| MOB-2375CT | Recombinant Mouse anti-Human KRT2 Monoclonal antibody (TCG6) | WB, IHC-P, IHC-Fr | |
| MRO-0445-CN | Recombinant Rabbit Anti-KRT2 Monoclonal Antibody (CBACN-183) | WB, IHC | Rabbit IgG |
| VS3-FY2757 | Mouse Anti-KRT2 Recombinant Antibody (VS3-FY2757) | WB, IHC, ICC, FC, ELISA | Mouse IgG |
| VS7-0425-WR262 | Mouse Anti-KRT2 Recombinant Antibody (clone 1A2B5) | WB, IHC, ICC, FC | Mouse IgG2a |
| VS7-0425-WR263 | Mouse Anti-KRT2 Recombinant Antibody (clone 8A1E1) | IHC, ICC | Mouse IgG2a |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for VS3-CJ912. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
-2.png)
Application: FuncS, IF, Neut, ELISA, FC, IP, ICC
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: WB, ELISA, IP, FC, FuncS, Neut, IF
Application: FC, IP, ELISA, Neut, FuncS, IF, WB
Application: WB, FC, IP, ELISA, Neut, FuncS, IF
Application: WB, FuncS, IF, Neut, ELISA, FC, IP
Application: FuncS, IF, Neut, ELISA, FC, IP, IHC
Application: Neut, Inhib, FC, ELISA
Application: Neut, FC, IHC-Fr, IP, BA
Application: Block, IP, IF, FC
Application: ELISA, FC, Neut, Inhib
Application: Neut, ELISA, IF, IP, FuncS, FC
For Research Use Only. Not For Clinical Use.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
